Acrivon Therapeutics, Inc. License Agreements
2 Contracts & Agreements
- Patent License Agreement, by and between the Registrant and Peter Blume-Jensen, dated April 12, 2018 (Filed With SEC on October 17, 2022)
- License Agreement, by and between the Registrant and Eli Lilly and Company, dated January 27, 2021 (Filed With SEC on October 17, 2022)
